神経内分泌腫瘍の肝病変に対する degradable starch microspheres (DSM) 併用動注化学塞栓療法(DSM-TACE)の検討  [in Japanese] Transcatheter arterial chemoembolization (TACE) using degradable starch micro-spheres (DSM) (DSM-TACE) for primary and metastatic liver neuroendocrine tumors from gastrointestinal neuroendocrine tumors  [in Japanese]

Access this Article

Search this Article

Author(s)

Abstract

神経内分泌腫瘍10症例(原発性: 1例,転移性: 9例)の肝病変に対するdegradable starch microspheres(DSM)併用動注化学塞栓療法の合併症と抗腫瘍効果を検討した.奏功率は70.0%で,50%生存期間は852日(28.4カ月),1年生存率,2年生存率とも77.8%であった.神経内分泌腫瘍の肝病変において肝動脈化学塞栓療法は非手術的な治療のうち最も有効な治療となると考えられた.<br>

We reviewed the efficacy and complications of transcatheter arterial chemoembolization using degradable starch microspheres (DSM) for primary neuroendocrine tumors of the liver or liver metastases from gastrointestinal neuroendocrine tumors in ten patients. The rate of complete and partial response was 70.0%. The one year and two year survival rate was 77.8% respectively, with a median survival time of 852 days (28.4 months). All symptoms and laboratory data related to treatment were acceptable. It is thought that DSM-TACE is an effective treatment for inoperable liver neuroendocrine tumors or liver metastases from gastrointestinal neuroendocrine tumors.<br>

Journal

  • Nippon Shokakibyo Gakkai Zasshi

    Nippon Shokakibyo Gakkai Zasshi 105(2), 206-213, 2008-02-05

    The Japanese Society of Gastroenterology

References:  25

Cited by:  1

Codes

  • NII Article ID (NAID)
    10021270418
  • NII NACSIS-CAT ID (NCID)
    AN00192124
  • Text Lang
    JPN
  • Article Type
    Journal Article
  • ISSN
    04466586
  • Data Source
    CJP  CJPref  J-STAGE 
Page Top